Parker, Christopher C ;
James, Nicholas D ;
Brawley, Christopher D...
Parker , C C , James , N D , Brawley , C D , Clarke , N W , Hoyle , A P , Ali , A , Ritchie , A W S , Attard , G , Chowdhury , S , Cross , W , Dearnaley , D P , Gillessen , S , Gilson , C , Jones , R J , Langley , R E , Malik , Z I , Mason , M D , Matheson , D , Millman , R , Russell , J M , Thalmann , G N , Amos , C L , Alonzi , R , Bahl , A , Birtle , A , Din , O , Douis , H , Eswar , C , Gale , J , Gannon , M R , Jonnada , S , Khaksar , S , Lester , J F , O'sullivan , J M , Parikh , O A , Pedley , I D , Pudney , D M , Sheehan , D J , Srihari , N N , Tran , A T H , Parmar , M K B & Sydes , M R 2018 , ' Radiotherapy to the primary tumour for newly diagnosed, metastatic prostate cancer (STAMPEDE): a randomised controlled phase 3 trial ' , The Lancet , vol. 392 , no. 10162 , pp. 2353-2366 . https://doi.org/10.1016/S0140-6736(18)32486-3.
,
2018
